Patient recruitment and data collection is ongoing
LLDAS Validation Study
First multi-national, prospective, validation study of Lupus Low Disease Activity State (LLDAS) as a treat-to-target (T2T) endpoint, demonstrating that LLDAS attainment provides significant protection from organ damage accrual and flare in patients with systemic lupus erythematosus (SLE).
T2T -SLE Study
Extension and expansion of LLDAS validation study aimed to capture longer follow up data and more patient recruitment to further examine LLDAS and remission definitions.
Outcomes in SLE
Planned future study. Watch this space!